Amphastar Pharmaceuticals Inc.

AMPH | NDAQ

Overview

Corporate Details

ISIN(s):: US03209R1032 (+3 more)
LEI:: 54930055TH0ZLSAQMJ38
Country:: United States of America
Address:: 850 NEW BURTON ROAD, 19904 DOVER
Website:: https://amphastar.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Amphastar Pharmaceuticals Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
2025-09-03 00:00	Investor Presentation Wells Fargo Healthcare Presentation	English	3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
H. Lundbeck A Global pharmaceutical company creating innovative treatments for brain diseases.	Denmark	HLUN
Hutchmed (China) Limited	Hong Kong	N/A
Hyloris Pharmaceuticals SA A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.	Belgium	HYL
Idorsia Ltd Develops novel medicines for CNS, cardiovascular, immunological, and orphan diseases.	Switzerland	IDIA
Immuno-Biological Laboratories Co., Ltd.	Japan	4570
Indivior PLC A global pharmaceutical firm developing treatments for addiction and mental illness.	United Kingdom	INDV
Infant Bacterial Therapeutics Developing microbiome therapies for premature infants to prevent life-threatening intestinal disease.	Sweden	IBT
Intercure Ltd. Producer of pharma-grade, GMP-certified medical cannabis products for patients outside North America.	Israel	INCR
Intervacc AB Develops recombinant protein vaccines for animal health, led by its vaccine for equine strangles.	Sweden	IVACC
Ipsen Develops transformative medicines for Oncology, Rare Diseases, and Neuroscience.	France	IPN